Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kai C Wollert

Showing results (1-10 of 181) with videos related to

Pageof 19
Sort By:
Current Opinion in Pharmacology|February 5, 2008
Cell therapy for acute myocardial infarctionKai C Wollert
Heart (British Cardiac Society)|January 21, 2015
Bone marrow mononuclear cell therapy for acute myocardial infarction: we know what we want, but we just don't know how yetKai C Wollert
Basic Research in Cardiology|June 5, 2007
Growth-differentiation factor-15 in cardiovascular disease: from bench to bedside, and backKai C Wollert
JACC. Basic to Translational Science|September 1, 2018
Follistatin-Like 1: Growing Evidence for Its Beneficial Role in Heart FailureKai C Wollert
European Heart Journal|December 10, 2015
Ischaemic risk and bleeding risk in acute coronary syndrome: still inseparableKai C Wollert
European Heart Journal|May 22, 2012
Tailored therapy for heart failure: the role of biomarkersKai C Wollert
European Journal of Heart Failure|October 18, 2018
Growth differentiation factor-15 reveals the dark side of heart failureKai C Wollert
Circulation|March 14, 2022
Response by Wollert to Letter Regarding Article, "Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure"Kai C Wollert
Critical Care (London, England)|August 3, 2013
Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndromeTibor Kempf, Kai C Wollert
European Journal of Heart Failure|October 11, 2012
GDF-15 in heart failure: providing insight into end-organ dysfunction and its recovery?Kai C Wollert, Tibor Kempf
Pageof 19

Showing results (1-10 of 181) with videos related to

Sort By:
Pageof 19
Current Opinion in Pharmacology|February 5, 2008
Cell therapy for acute myocardial infarctionKai C Wollert
Heart (British Cardiac Society)|January 21, 2015
Bone marrow mononuclear cell therapy for acute myocardial infarction: we know what we want, but we just don't know how yetKai C Wollert
Basic Research in Cardiology|June 5, 2007
Growth-differentiation factor-15 in cardiovascular disease: from bench to bedside, and backKai C Wollert
JACC. Basic to Translational Science|September 1, 2018
Follistatin-Like 1: Growing Evidence for Its Beneficial Role in Heart FailureKai C Wollert
European Heart Journal|December 10, 2015
Ischaemic risk and bleeding risk in acute coronary syndrome: still inseparableKai C Wollert
European Heart Journal|May 22, 2012
Tailored therapy for heart failure: the role of biomarkersKai C Wollert
European Journal of Heart Failure|October 18, 2018
Growth differentiation factor-15 reveals the dark side of heart failureKai C Wollert
Circulation|March 14, 2022
Response by Wollert to Letter Regarding Article, "Myeloid-Derived Growth Factor Protects Against Pressure Overload-Induced Heart Failure"Kai C Wollert
Critical Care (London, England)|August 3, 2013
Risk stratification in critically ill patients: GDF-15 scores in adult respiratory distress syndromeTibor Kempf, Kai C Wollert
European Journal of Heart Failure|October 11, 2012
GDF-15 in heart failure: providing insight into end-organ dysfunction and its recovery?Kai C Wollert, Tibor Kempf
Pageof 19